Impact of a Multidisciplinary Tumor Board on the Care of Patients with Histiocytic Disorders: The Histiocytosis Working Group experience.
Oncologist
; 27(2): 144-148, 2022 03 04.
Article
in English
| MEDLINE | ID: covidwho-2190090
ABSTRACT
INTRODUCTION:
Histiocytic disorders pose significant diagnostic and management challenges for the clinicians due to diverse clinical manifestations and often non-specific histopathologic findings. Herein, we report the tumor board experience from the first-of-its-kind Histiocytosis Working Group (HWG). MATERIALS ANDMETHODS:
The HWG was established in June 2017 and consists of experts from 10 subspecialties that discuss cases in a multidisciplinary format. We present the outcome of tumor board case discussions during the first 2 years since its inception (June 2017-June 2019).RESULTS:
Forty cases with a suspected histiocytic disorder were reviewed at HWG during this time period. Average number of subspecialties involved in HWG case discussion was 5 (range, 2-9). Histiocytosis Working Group tumor board recommendations led to significant changes in the care of 24 (60%) patients. These included change in diagnosis (n = 11, 27%) and change in treatment (n = 13, 33%).CONCLUSION:
Our report highlights the feasibility of a multidisciplinary tumor board and its impact on outcomes of patients with histiocytic disorders.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Histiocytosis
/
Neoplasms
Type of study:
Diagnostic study
/
Experimental Studies
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Oncologist
Journal subject:
Neoplasms
Year:
2022
Document Type:
Article
Affiliation country:
Oncolo
Similar
MEDLINE
...
LILACS
LIS